Table 3.
TB screening algorithm costs among persons with clinical and structural risk factors
| First author, Year | Country | Screening algorithm | Source of unit costs | Type of unit costs | Average cost1 of screening per person | Average cost1 of diagnosis per person | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Screening | Diagnostic tests | Staff | Equipment | Consumables | Overhead | Transport | TB Treatment | |||||||
| Persons with structural risk factors (N = 16)a | ||||||||||||||
| Migrants, refugees, internally displaced persons (IDPs) | ||||||||||||||
| Bogdanova 2019 | Russia | Mass CXR screening | SSM | Reported | ✓ | ✓ | ✓ | $4 per migrant screened | $834 per TB case diagnosed | |||||
| Smit 2017 | Belgium | WHO 4SS, CXR | NR | Calculated | ✓ | ✓ | $18 per migrant screened | $506,025 per migrant diagnosed with TB | ||||||
| NR | $6721 per asylum seeker diagnosed with TB | |||||||||||||
| Homeless persons and intravenous drug users (IDUs) | ||||||||||||||
| Bogdanova 2019 | Russia | Mass CXR screening | SSM | Reported | ✓ | ✓ | ✓ | $4-$13 | $793 per TB case diagnosed | |||||
| Jit 2011 | United Kingdom | Mobile CXR screening for IDUs and homeless | NR | Reported | ✓ | ✓ | ✓ | ✓ | ✓ | NR |
$9837 per QALY gained (UR: $6,302-$27,666) |
|||
| Persons who live in urban slums | ||||||||||||||
| Sekandi 2015 | Uganda | WHO 4SS for all HHC |
SSM and CXR |
Reported | ✓ | ✓ | ✓ | ✓ | NR | $1371 per additional TB case diagnosed | ||||
| Shah 2017 | Peru | Household visits for WHO 4SS for all HHC | Xpert MTB/RIF | Reported | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | $32 per person screened | $3244 per DALY averted | ||
| James 2017 | Cambodia | Door-to-door WHO 4SS | SSM and Xpert | Reported | ✓ | ✓ | ✓ | NR | $268 per TB case diagnosed | |||||
| Members of tribal or indigenous populations | ||||||||||||||
| Sohn 2019 | India | Household visits for TB education and screening | SSM | Reported | ✓ | ✓ | ✓ | < $1 per person screened | $3–5 per TB case diagnosed | |||||
| Persons residing in prisons | ||||||||||||||
| Machekera 2019 | Zimbabwe | WHO 4SS, CXR | Xpert MTB/RIF | Calculated | ✓ | ✓ | $14 per person screened | $460 per TB case diagnosed | ||||||
| Smit 2017 | Belgium | WHO 4SS, CXR | NR | Calculated | ✓ | ✓ | $18 per person screened | $14,034 per TB case diagnosed | ||||||
| Winetsky 2012 | Former Soviet Union | WHO 4SS alone | NR | Reported | ✓ | ✓ | ✓ | ✓ | $3 per person screened | $538 per QALY gained | ||||
| MMR (CXR) | NR | Reported | ✓ | ✓ | ✓ | ✓ | $5 per person screened | |||||||
| Xpert MTB/RIF | NR | Reported | ✓ | ✓ | ✓ | ✓ | $2 per person screened | |||||||
| Zishiri 2014 | South Africa | WHO 4SS | Xpert MTB/RIF | Reported | ✓ | ✓ | ✓ | ✓ | ✓ | $33 per person screened | $1423 TB case diagnosed | |||
| Elderly (55 +) | ||||||||||||||
| Jo 2020 | Cambodia (> 55) | Symptom screen | Xpert, SSM, CXR | Reported | ✓ | ✓ | ✓ | ✓ | ✓ | < $1 per person screened | $406 per TB case diagnosed | |||
| James 2017 | Cambodia (> 55) | Symptom screen | Xpert, CXR | Calculated | ✓ | ✓ | ✓ | ✓ | < $2 per person screened | $340 per TB case diagnosed | ||||
| Zhang 2017 | China (> 65) | Door-to-door symptom screen or CXR | CXR, SSM, culture | Reported | ✓ | ✓ | ✓ | ✓ | NR | $74–$315 per TB case diagnosed | ||||
| People living in areas with limited access to healthcare (remote, isolated, hard-to-reach areas) | ||||||||||||||
| Karki 2017 | Papua New Guinea | Community-wide symptom screening | SSM | Reported | ✓ | ✓ | ✓ | NR | $158 per TB case diagnosed | |||||
| Jo 2020 | Cambodia | Symptom screen | Xpert, SSM, CXR | Reported | ✓ | ✓ | ✓ | ✓ | ✓ | < $1 per person screened | $406 per TB case diagnosed | |||
| Miners (i.e., workers with silica exposure) | ||||||||||||||
| Machekera 2019 | Zimbabwe | WHO 4SS, CXR | Xpert MTB/RIF | Calculated | ✓ | ✓ | $14 per person screened | $404 per miner diagnosed | ||||||
| Persons with clinical risk factors (N = 3)b | ||||||||||||||
| Diabetes mellitus | ||||||||||||||
| Bogdonova 2019 | Russia | CXR | SSM | Reported | ✓ | ✓ | ✓ | NR | $21,780 per TB case diagnosed | |||||
| Ji 2020 | China | CXR | SSM | Calculated | ✓ | ✓ | ✓ | ✓ | < $2 per person screened | $288 per DALY averted | ||||
| Machekera 2019 | Zimbabwe | CXR | Xpert | Reported | ✓ | ✓ | ✓ | NR | $2191 per TB case diagnosed | |||||
| Respiratory disease | ||||||||||||||
| Bogdonova 2019 | Russia | CXR | SSM | Reported | ✓ | ✓ | ✓ | NR | $32,746 per TB case diagnosed | |||||
| Gastro-intestinal, genito-urinary, steroid use or fibrotic chest lesions | ||||||||||||||
| Bogdonova 2019 | Russia | CXR | SSM | Reported | ✓ | ✓ | ✓ | NR | $11,648-$105,754 per TB case diagnosed | |||||
aThere is limited evidence on screening among persons with structural risk factors, including migrants (n = 2), homeless persons and IDUs (n = 2), persons who live in urban slums (n = 3), members of tribal or indigenous populations (n = 1), persons residing in prisons (4), elderly (3), people living in remote areas (n = 2) and miners (1). The costs of screening among persons with structural risk factors ranged from $1–33 per person screened and $3–$506,025 per TB case diagnosed. Screening programs were found to be cost-effective in persons living in urban slums and homeless, with reported ICERs of $3244 per DALY averted and $9837 per QALY, respectively. Screening was not shown to be cost-effective in migrants with an of ICER $506,025 per migrant diagnosed. In the Former Soviet Union, screening persons residing in prisons was found to be cost-effective with an ICER of $538 per QALY gained. Door-to-door screening of the elderly in China was shown to be cost-effective with ICERs ranging from US$74 to $315 per additional TB patient diagnosed
bThere is limited evidence on screening among persons with clinical risk factors, primarily from one study in Russia. One study in Russia demonstrated a cost ranging from $11,648 to $105,754 for systematic screening among persons with various clinical risk factors (i.e., gastro-intestinal, respiratory disease, genito-urinary, steroid use and fibrotic chest lesions). Two studies conducted in Russia and Zimbabwe reported the cost per person diagnosed with diabetes mellitus (DM) which ranged from $2191 to $21,780. A cost-effectiveness analysis of patients with DM in China found systematic screening using CXR was cost-effective with an ICER of $288 per DALY averted
ACF active case finding, HHC household contacts, SSM sputum smear microscopy, Xpert GeneXpert, WHO 4SS four symptom screen, mWRDs molecular WHO-approved rapid diagnostics, CXR chest x-ray, NR not reported
1Costs in 2019 USD unless stated otherwise
‘✓’ indicates cost component was explicitly included in unit cost calculation